COVID-19: How many antibodies are enough? - opinion

Evusheld is a new medication from AstraZeneca designed specifically for people who are immunocompromised.

TESTING CHILDREN aged 3 to 12 for antibodies, in Katrin, Aug. 2021.

TESTING CHILDREN aged 3 to 12 for antibodies, in Katrin, Aug. 2021.

(photo credit: MICHAEL GILADI/FLASH90)

MARCH 10, 2022 17:35

Updated: MARCH 13, 2022 13:30

RECOMMENDED STORIES

Firefighters work at the site of a warehouse hit by a Russian drone strike, amid Russia's attack on Ukraine, in Odesa, Ukraine June 3, 2025.

North Korea to send 30,000 soldiers to frontlines as Washington weighs support for Ukraine

JULY 2, 2025

An Iron Dome launcher fires an interceptor missile as rockets are fired from Gaza, in Sderot, Israel, May 10, 2023.

Three rockets of unknown origin fall in Iraq, Iranian media claim five drone strikes

JULY 1, 2025

Palestinians gather to collect aid supplies from the U.S.-backed Gaza Humanitarian Foundation, in Khan Younis, in the southern Gaza Strip, May 29, 2025.

'They shoot people deliberately': Gazans testify that Hamas intentionally targets aid sites

JULY 1, 2025

Islamic Revolutionary Guard Corps (IRGC) Commander-in-Chief Major General Hossein Salami reviews military equipment during an IRGC ground forces military drill in the Aras area, East Azerbaijan province, Iran, October 17, 2022.

Mossad to Tehran: We already know your ‘secret’ war commander

JULY 1, 2025

Hot Opinion

Frustration with our leadership must not lead to our annihilation

ByJPOST EDITORIAL

Michael Masters

A dangerous new chapter: The threat of North American domestic terror

ByMICHAEL MASTERS

An Iron Dome of values: Israel's future lies in Herzl's vision

ByIRINA NEVZLIN

Poor habits cause death more than disease

ByALAN FREISHTAT